Navigation Links
Rosetta Genomics Expands Management Team, Laboratory Capacities and Commercial Operations
Date:8/20/2012

ion he will lead efforts aimed at licensing and/or acquiring new opportunities.
  • Steve Miller joined the Company in June 2012 in the newly created position of Director of Marketing and Reimbursement.  Prior to Rosetta Mr. Miller operated his own marketing and reimbursement consultancy business.  Previously he spent nine years at Veridex, LLC, a Johnson & Johnson company focused on oncology medical devices and diagnostics, where he was Worldwide Product Director with responsibility for brand P&L, and the development and execution of annual marketing plans.  During his last two years with Veridex, Mr. Miller also played a key leadership role in brand reimbursement efforts. Prior to that he was Worldwide Product Director for the Ortho-Clinical Diagnostics blood donor screening franchise. Mr. Miller received a higher technical diploma in Applied Biology from the North East Surrey College of Technology in the UK.  Mr. Miller will focus on driving adoption of Rosetta's marketed assays as well as widening the insurance coverage for these assays.
  • "It is with great pleasure that I welcome Ron, Guy and Steve to the Rosetta team.  Their collective experience, relationships and know-how will be invaluable as we work to capitalize on our powerful and versatile microRNA platform and as we leverage our growing commercial operation to expand product sales and attract potential partnerships and collaborations," added Mr. Berlin.

    About Rosetta GenomicsRosetta develops and commercializes a full range of microRNA-based molecular diagnostics.  Founded in 2000, Rosetta's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong patent position and proprietary platform technologies, Rosetta is working on the application of these technologies in the development and commercialization
    '/>"/>

    SOURCE Rosetta Genomics Ltd.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. Rosetta Genomics Receives 2012 North American Entrepreneurial Company of the Year Award by Frost & Sullivan
    2. Rosetta Genomics Announces Closing of Public Offering of 5.5 Million Ordinary Shares
    3. Rosetta Genomics Pays Off Secured Loan and Reclaims Unencumbered Rights to All Assets
    4. First Plant Genomics Yield Technology Progresses
    5. Synthetic Genomics Inc. Purchases 81 Acre Site in South California Desert for Scale up and Testing of Innovative Algae Strains
    6. Rubicon Genomics and Agendia Sign Agreement for Use of TransPLEX® Whole Genome RNA Amplification Technology With Symphony™ Cancer Diagnostics
    7. New England Biolabs Signs Agreement with Synthetic Genomics Inc. to Launch Gibson Assembly™ Master Mix for Molecular and Synthetic Biology Applications
    8. Synthetic Genomics Inc. Hires Industry Leader George E. Stagnitti to Head Food and Nutritional Products Development Program
    9. Elsevier Expands Access to Digital Offerings Through Collaboration with Follett
    10. BioStorage Technologies Expands its Service Offering to Include Advanced Bioprocessing Solutions
    11. Celltex Therapeutics Corporation Expands Laboratory Operations And Adds Depth To Its Management Team
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/24/2014)... group leader Yung-Eun Sung has announced that they ... nitrogen-doped graphenes which can be applied as high ... Yung-Eun Sung is both a group leader at ... Basic Science* (IBS) and a professor at the ... significance with regards to the development of relative ...
    (Date:7/24/2014)... prefer to settle into equilibriuma state of unchanging ... realm of non-equilibrium conditions where new possibilities lie. ... phases, such as temperature fluctuations, freezing and melting, ... their body temperature, airplanes to fly, and the ... But even though these conditions exist naturally and ...
    (Date:7/24/2014)... Your cell phone may stay charged ... storage capacity. , New research indicates that lithium-ion ... at Lawrence Livermore National Laboratory and ... components will perform as electrodes. , The growing ... for higher-performance batteries. Several key characteristics of lithium-ion ...
    (Date:7/24/2014)... CA (PRWEB) July 24, 2014 Three ... be semi-finalists in Livestrong’s Big C Competition. Out of ... are each headed to the semi-final round. In this ... exclusive three-month accelerator program, complete with mentoring from thought-leaders ... , As part of the angelMD commitment to the ...
    Breaking Biology Technology:New approach to form non-equilibrium structures 2Getting More Life out of Lithium-ion Batteries 23 angelMD Startups Make Livestrong Big C Semi-finals 2
    ... 16 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS;,Nasdaq: PXSL) today ... for its asthma management product, Aridol., "This ... Pharmaxis Chief,Executive Officer Dr Alan Robertson. "Korea is ... Aridol in Asia. There are an estimated 2.5 ...
    ... 16 /PRNewswire-FirstCall/ - Vasogen Inc.,(NASDAQ: VSGN ; TSX:VAS), ... year ended November 30, 2007. All dollar amounts ... At November 30, 2007, our cash and ... at November 30, 2006. The change in,our cash ...
    ... 16 Bristol-Myers Squibb,Company (NYSE: BMY ) will ... 2007 on Thursday, January 31. During a 10 a.m. ... financial information and will,address inquiries from investors and analysts., ... listen to a live,webcast of the call at ...
    Cached Biology Technology:Pharmaxis' Aridol Gains First Asian Approval 2Vasogen Announces 2007 Year-End Results 2Vasogen Announces 2007 Year-End Results 3Vasogen Announces 2007 Year-End Results 4Vasogen Announces 2007 Year-End Results 5Vasogen Announces 2007 Year-End Results 6Vasogen Announces 2007 Year-End Results 7Vasogen Announces 2007 Year-End Results 8Vasogen Announces 2007 Year-End Results 9Vasogen Announces 2007 Year-End Results 10Vasogen Announces 2007 Year-End Results 11
    (Date:7/25/2014)... link between autism and disrupted brain development is ... disease, and is largely unknown. However, thanks to ... (SFARI), George Washington University (GW) researcher Anthony-Samuel LaMantia, ... and in-depth answers to these key questions in ... professor of pharmacology and physiology at the GW ...
    (Date:7/25/2014)... research at the University of Adelaide has opened the way ... to powdery mildew. , In Australia, annual barley production is ... Powdery mildew is one of the most important diseases of ... have discovered the composition of special growths on the cell ... fungus into the leaf. , The research, by the ARC ...
    (Date:7/25/2014)... MOResearchers at the Stowers Institute for Medical Research ... pheromone receptors, and found pheromones crucial to triggering the ... of receptors helps a male mouse detect pheromones that ... of receptors lets him know if the female mouse ... pheromones are critical to trigger mating. Stowers, researchers believe ...
    Breaking Biology News(10 mins):GW researcher receives grant to answer the how and why of autism during development 2New hope for powdery mildew resistant barley 2It takes two to court 2It takes two to court 3
    ... wife doesn,t feel good on the Pill. He,d like to have ... responsibility for contraception. But they want another child, so vasectomy is ... drops his electric car off for a quick charge, he pops ... minutes of ultrasound treatment, for 6 months of contraception. Sound ...
    ... to help assess the spread and impact of the Deepwater ... the request of U.S. disaster response agencies. As part ... instrumented research aircraft the Earth Resources-2 (ER-2) to the Gulf ... observations and conducting additional data processing to assist the National ...
    ... attempt to silence the biochemical conversations that disease-causing bacteria ... a study in ACS, monthly journal, Biomacromolecules , ... soak up the substances that bacteria produce and pass ... and colleagues point out that more and more disease-causing ...
    Cached Biology News:No more pills: Male contraceptive takes new approach 2No more pills: Male contraceptive takes new approach 3No more pills: Male contraceptive takes new approach 4NASA deploys planes, targets satellites to aid in oil spill response 2NASA deploys planes, targets satellites to aid in oil spill response 3
    RORgamma (S-14)...
    ... Sophions newly introduced QPatch HT is taking ... more powerful level. With its ability to generate ... HT is enabling new screening paradigms in ion ... clamping with the same high quality afforded by ...
    ... aptamer screening and binding optimization and built ... on-chip synthesis platform. These microarrays are available ... Microarray Service. Probe Content ... than 1500 known aptamer sequences. Add up ...
    ... provides a comprehensive epitope analysis service ... on Paraflo microfluidic chips for immunological ... This comprehensive service includes assistance with ... sample(s) provided by you, single or ...
    Biology Products: